Trials / Completed
CompletedNCT01634035
Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients
Correlation Between Glycated Hemoglobin and Mean Plasma Glucose in Hemodialysis Patients.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 159 (actual)
- Sponsor
- Northwell Health · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The investigators are studying the correlation between Hba1c and the mean plasma glucose in diabetic hemodialysis patients.We are reviewing if HbA1c is a good clinical tool to assess glycemic control over a 3 months duration in hemodialysis patients
Detailed description
The Hb turnover in hemodialysis population is higher than the general population leading to a general believe that HbA1c tend to underestimate mean plasma glucose. The investigators are trying to define the correlation between mean plasma glucose and HbA1c in the hemodialysis population and trying to study the factors that could affect this correlation (dose of erythropoetin, ret count..) We are trying to see if HbA1c is a better tool to assess glycemic control over 1 month than glycemic control over 3 month. This clinicaly will translate in obtaining HbA1c more frequently in hemodialysis patients to assess their glycemic control.
Conditions
Timeline
- Start date
- 2009-03-01
- Primary completion
- 2009-05-01
- Completion
- 2009-05-01
- First posted
- 2012-07-06
- Last updated
- 2012-07-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01634035. Inclusion in this directory is not an endorsement.